Fact CheckerSign in

NCT07483749Not yet recruiting

HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors

A Multicenter Prospective Study on Structuralized Follow-up Model Construction and Late Effect Burden of Childhood Hematological Malignancy Survivors (HEM-SURVIVE)

Source: ClinicalTrials.gov · Last updated 19 Mar 2026

Brief summary (registry, in English)

This study aims to construct a structuralized follow-up model for survivors of childhood hematological malignancies in China. Using a multicenter prospective cohort design, it will identify the burden and risk factors of late effects. The study hypothesizes that a standardized follow-up path managed by an electronic platform will improve follow-up compliance and reduce the missed diagnosis rate of late effects.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
400 (estimated)
First submitted
2 Mar 2026
Start date
25 Mar 2026
Primary completion date
Dec 2028
Lead sponsor
The Children's Hospital of Zhejiang University School of Medicine
NCT number
NCT07483749

What you commit to

  • Study type: Observational
  • Planned participants: 400
  • From 25 Mar 2026 to the primary completion date, Dec 2028
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe organ failure preventing follow-up.
  • Major genetic or systemic diseases affecting growth/organ function.

Other

  • Expected poor compliance or refusal to participate.

Who the study is looking for

  • Diagnosed with childhood hematological malignancies (ALL, AML, Lymphoma, etc.), Completed primary treatment for ≥12 months.
  • Age 1-21 years.
  • Capable of completing follow-up and data collection.
  • Informed consent signed.

Age in the registry: 1 year to 21 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Children's Hospital, Zhejiang University School of Medicine
Coordinator of this site? Confirm its status
HangzhouChinaUnknown status
Hangzhou Children's Hospital
Coordinator of this site? Confirm its status
HangzhouChinaUnknown status
Affiliated Women and Children's Hospital of Ningbo University
Coordinator of this site? Confirm its status
NingboChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.